Organ Failure, Multiple Clinical Trial
Official title:
Impact of Fourier Transform Infrared Spectroscopy (FTIRS) on the Diffusion of ESBL Producing Enterobacterales in Intensive Care Units (ICU)
This study will assess the impact of FTIRS typing on the spread of ESBL-E in intensive care units
Multidrug resistant enterobacterales (MDR-E) are a major threat for patients hospitalized in intensive care units (ICUs). To prevent MDR-E spread in ICUs, rectal swabs are routinely performed and cultured on selective media. However, bacterial identification and antimicrobial susceptibility results are not sufficient to diagnose cross transmissions. The gold standard technique is based on genomic analysis that require whole genome sequencing (WGS) of bacteria and followed by multilocus sequence typing (MLST) and Single Nucleotide Polymorphism (SNP) typing. This technology is rather expensive and not applicable in all centers. Fourier Transform InfraRed Spectroscopy (FTIRS) is a developing method for rapid bacterial typing. This technology is simple and results can be obtained in one hour. It is therefore adapted to continuous surveillance of MDR-E. In France, extended spectrum betalactamase producing enterobacteriaceae (ESBL-E) represent the vast majority of MDR-E. We postulate that early diagnosis of cross-transmission by FTIRS may prevent the spread of ESBL-E in ICUs and favor compliance with hygiene measures. The aim of this study will be to assess the impact of systematic FTIRS typing of ESBL-E on ESBL-E cross-transmissions in ICUs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02520440 -
INtestinal Failure, multiPle Organ Failure ANd CItrulline Assessment
|
N/A | |
| Recruiting |
NCT04695119 -
Sepsis in the ICU-II
|
||
| Not yet recruiting |
NCT04502511 -
Heterogeneity of Critical Illness: a Cohort Study
|
||
| Recruiting |
NCT03825250 -
The Val-CARD Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT03344627 -
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
|
N/A | |
| Completed |
NCT04772703 -
DNA Damage in Critically Ill COVID-19 Patients
|
||
| Recruiting |
NCT06452966 -
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04015973 -
The PRE-OP ENERGY Trial
|
N/A | |
| Withdrawn |
NCT03933930 -
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
|
N/A | |
| Completed |
NCT03075605 -
PROOF: Pancreatitis-associated Risk Of Organ Failure
|
||
| Not yet recruiting |
NCT06330610 -
Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit
|
N/A | |
| Recruiting |
NCT03547232 -
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
|
Phase 4 | |
| Not yet recruiting |
NCT03282253 -
Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis
|
N/A | |
| Completed |
NCT05972980 -
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
|
||
| Withdrawn |
NCT03167788 -
Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery
|
Phase 2 | |
| Recruiting |
NCT05405426 -
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
|
N/A | |
| Completed |
NCT04732481 -
Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.
|